L&C Bio Co., Ltd (290650.KQ) KOE
78,800.00
+4700(+6.34%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.5T |
| Enterprise Value | 1.57T |
| P/E Ratio | -15.17 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 19.53 |
| Price/Book Ratio | 10.11 |
| Enterprise/Revenue | 19.98 |
| Enterprise/EBITDA | 113.34 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.38 |
| Operating Margin | 0.11 |
Management Effectiveness
| Return On Assets | -0.29 |
| Return On Equity | -0.56 |
Income Statement
| Revenue | 85.48B |
| Revenue/Share | 3,770.06 |
| Gross Profit | 41.32B |
| EBITDA | 11.57B |
| Net Income | -138.17B |
| Diluted EPS | -5,811.4 |
Balance Sheet
| Total Cash | 48.64B |
| Total Cash/Share | 1,869.18 |
| Total Debt | 87.49B |
| Total Debt/Equity | 0.43 |
| Current Ratio | 0.64 |
| Book Value Per Share | 8,194.04 |
Price History
| 52-Week Change | 184.48 |
| 52-Week High | 125,000 |
| 52-Week Low | 25,500 |
| Moving Average 50 Days | 68,554 |
| Moving Average 200 Days | 63,718.5 |
Statistics
| Average Volume | 273,877 |
| Shares Outstanding | 24.32M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 0.06 |
| Payout Ratio | -0.01 |
| Last Split Factor | 3:1 |
| Last Split Date | October 12, 2020 |
